There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - Senate

Short Title(s) as Introduced

End Taxpayer Subsidies for Drug Ads Act

Official Titles

Official Titles - Senate

Official Titles as Introduced

A bill to amend the Internal Revenue Code of 1986 to deny the deduction for advertising and promotional expenses for prescription drugs.

Actions Overview (1)

Date Actions Overview
01/28/2021Introduced in Senate

All Actions (1)

Date All Actions
01/28/2021Read twice and referred to the Committee on Finance.
Action By: Senate

Cosponsors (22)

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Related Documents
Senate Finance01/28/2021 Referred to

As of 05/15/2021 no related bill information has been received for S.141 - End Taxpayer Subsidies for Drug Ads Act

Subjects (5)

Latest Summary (1)

There is one summary for S.141. View summaries

Shown Here:
Introduced in Senate (01/28/2021)

End Taxpayer Subsidies for Drug Ads Act

This bill prohibits a tax deduction for expenses relating to direct-to-consumer advertising of prescription drugs.

Direct-to-consumer advertising is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is in regard to the drug product and primarily targeted to the general public.